Abstract
IntroductionThis study was conducted with an objective to analyze prevalence and risk factors associated with co-infection of hepatitis B virus (HBV) and hepatitis C virus (HCV) in HIV-positive patients with reference to their CD4+ T cell status.Materials and methodsHIV-positive patients visiting the HIV clinic for CD4+ T cells testing at B.P. Koirala Institute of Health Sciences were tested for Hepatitis B and Hepatitis C. Data regarding age, gender, mode of HIV transmission, duration of HIV diagnosis, antiretroviral therapy status, antiretroviral therapy duration, hepatitis B or C status, and CD4+ T cells count were collected via face-to-face interview, and hospital records. The data were entered in Microsoft Excel 2019 v16.0 (Microsoft, WA, USA) and statistical analysis was performed by using statistical package for social sciences, IBM SPSS® v21 (IBM, Armonk, New York).ResultsOut of 474 HIV-positive patients, HIV-HBV, HIV-HCV, and HIV-HBV-HCV co-infections were seen in 2.95% (14/474), 18.14% (86/474), and 2.53% (12/474) respectively. The primary route of infection was intra-venous drug use (IVDU) in those co-infected with HBV only (8, 57.14%), HCV only (46, 53.49%), and both HBV and HCV (8, 66.67%). HIV patients infected via IVDU were 2.40 times more likely to have HIV-HCV co-infection as compared to those infected via sexual route (AOR 2.40, 95% CI: 1.49,3.86). Similarly, HIV patients with CD4+ T cells count less than 350 cells/mm3were more likely to have HIV-HBV-HCV co-infection as compared to those with CD4 count equal to and more than 350 cells/mm3(AOR 13.84, 95% CI: 2.90,66.10).ConclusionHIV-positive patients are at high risk of hepatitis B and/or hepatitis C co-infection. Intravenous drug use, and lower CD4+T cells count are the most important risk predictors of co-infection. All HIV-positive patients should be carefully screened with hepatitis B and hepatitis C tests during their follow-up.
Publisher
Public Library of Science (PLoS)
Reference26 articles.
1. Hepatitis viruses and human immunodeficiency virus co-infection: pathogenisis and treatment;A Vallet-Pichard;Journal of Hepatology,2004
2. Viral hepatitis and HIV in Africa;AA Modi;AIDS Rev,2007
3. Increasing burden of liver disease in patients with HIV infection;D Joshi;The Lancet,2011
4. Summarizing the results and methods of the 2019 Joint United Nations Programme on HIV/AIDS HIV estimates;KK Case;AIDS,2019
5. World Health Organization. Global health sector strategy on viral hepatitis 2016–2021 Geneva, Switzerland. 2016. [Internet]. [cited 2021 Oct 20]. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aids